Benserazide HCl (Ro-44602; Serazide; Ro 4-4602), the hydrochloride salt of Benserazide, is a carbohydrazide-based, peripherally acting inhibitor of aromatic L-amino acid decarboxylase/AADC or DOPA decarboxylase and a medication used in combination with levodopa (madopar) to treat Parkinson's disease, parkinsonism, and restless leg syndrome.

纯度：≥98%

CAS：14919-77-8